R1 RCM Inc represents a strong commitment to values and an effective corporate philosophy. The company prioritizes customer satisfaction by delivering high-quality services and innovative solutions. R1 RCM Inc focuses on integrity, ensuring transparency in its operations and maintaining trust with its stakeholders. The company also emphasizes teamwork, encouraging collaboration and fostering a positive work environment. R1 RCM Inc is dedicated to continuous improvement, constantly evolving and adapting to the changing needs of the healthcare industry. With a customer-centric approach and a dedication to excellence, R1 RCM Inc strives to be a leader in the healthcare revenue cycle management sector.

R1 RCM Inc is primarily present in the United States.

R1 RCM Inc has achieved significant milestones throughout its journey. The company has successfully positioned itself as a leader in the healthcare revenue cycle management industry. R1 RCM Inc has expanded its client base by forging strategic partnerships with various healthcare providers, enhancing its market presence and reputation. With a relentless focus on innovation and technology, R1 RCM Inc has achieved remarkable financial growth and operational efficiency. The company's commitment to delivering exceptional value and results has earned it recognition as one of the top performers in the industry. Overall, R1 RCM Inc has consistently surpassed expectations and continues to pave the way for excellence in healthcare revenue cycle management.

R1 RCM Inc, formerly known as Accretive Health Inc, is a leading provider of revenue cycle management solutions for healthcare organizations. Founded in 2003, R1 RCM Inc offers a comprehensive suite of services designed to optimize the financial performance of healthcare providers, including hospitals and physician groups. With its extensive expertise and advanced technology platforms, R1 RCM Inc helps its clients improve revenue capture, reduce costs, and enhance patient satisfaction. Over the years, R1 RCM Inc has established itself as a trusted partner in the healthcare industry, serving clients across the United States.

The main competitors of R1 RCM Inc in the market include Allscripts Healthcare Solutions, Cerner Corporation, and McKesson Corporation.

R1 RCM Inc is primarily active in the healthcare industry.

The business model of R1 RCM Inc revolves around providing revenue cycle management (RCM) solutions for healthcare organizations. R1 RCM offers end-to-end RCM services, including patient registration, coding, billing, and collections. By leveraging advanced technology and data analytics, R1 RCM helps healthcare providers optimize their financial performance, improve the patient experience, and enhance overall operational efficiency. With a focus on delivering value-based care, R1 RCM's business model is centered on driving revenue growth and financial sustainability for healthcare institutions.

R1 RCM KGV ir -72,73.

R1 RCM KUV ir 2,51.

AlleAktien kvalitātes vērtējums R1 RCM ir 4/10.

gaidāmā R1 RCM apgrozījums ir 2,56 miljardi USD.

gaidāmā R1 RCM peļņa ir -88,54 milj. USD.

R1 RCM is a leading company in the field of medical services and offers innovative solutions in the areas of billing, coding, process optimization, and patient registration. The business model of R1 RCM is based on providing services across various sectors. These include Revenue Cycle Management, Physician Advisory Services, Clinical Documentation Improvement, and Patient Registration. The company aims to support hospitals, clinics, and healthcare organizations in improving their operations while simultaneously reducing costs and enhancing the quality of care. Revenue Cycle Management is one of the key sectors of R1 RCM. The company provides comprehensive billing services that encompass the entire billing process, from capturing patient information to monitoring payment receipts. R1 RCM utilizes the latest technologies and automated processes to minimize errors and maximize efficiency. Physician Advisory Services is another sector of R1 RCM that focuses on optimizing medical documentation. Here, physicians and professionals collaborate to ensure that diagnoses and treatments are correctly documented and coded to ensure accurate billing and improve the quality of patient care. Clinical Documentation Improvement is another significant area of R1 RCM. In this sector, the company works to enhance the quality of medical documentation and the accuracy of diagnoses and treatments. By utilizing technology and analytical tools, the correct capture of information and data is ensured to optimize billing and enhance patient-related decision-making. Patient Registration is a crucial component of the R1 RCM business model. Patient information is captured and documented here to ensure smooth operations and accurate billing. By integrating technology and automation, R1 RCM is able to increase efficiency and reduce patient wait times. In addition to these services, R1 RCM also offers products specifically tailored to the needs of healthcare organizations. These include a medical coding platform, a patient registration platform, and a comprehensive data analysis platform that allows the company to gain valuable insights into operational processes. Overall, the business model of R1 RCM is focused on improving the efficiency and quality of care while simultaneously reducing costs. By leveraging technology, analytical tools, and automated processes, the company is able to support its clients optimally while also exploring new business opportunities.

R1 RCM izmaksā dividendes 0 USD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt R1 RCM vai uzņēmums nedod dividendes.

R1 RCM ISIN ir US7493971052.

R1 RCM WKN ir A2DK8W.

R1 RCM simbols ir RCM.

Pēdējo 12 mēnešu laikā R1 RCM maksāja dividendes apmērā. Tas atbilst aptuveni dividendes ražībai. Nākamajos 12 mēnešos R1 RCM plāno maksāt dividendes 0 USD apmērā.

R1 RCM pašreizējā dividendu rentabilitāte ir .

R1 RCM maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos .

R1 RCM pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 USD. Tas atbilst dividendes ražībai 0 %.

R1 RCM tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu R1 RCM apmērā 0 USD, kas tika izmaksāta 19.09.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 19.09.2024..

Pēdējās dividendes izmaksa notika 19.09.2024..

Gadā 2023, R1 RCM izmaksāja 0 USD dividendes.

R1 RCM dividendes tiek izmaksātas USD.